e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
The multiple facets of stem and progenitor cells in lung health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Winifred Broekman (Leiden, Netherlands), Winifred Broekman, Jan Stolk, Thais Mauad, Jaap Jan Zwaginga, Wim E. Fibbe, Jaap Oostendorp, Ingeborg Bajema, Michel I.M. Versteegh, Christian Taube, Pieter S. Hiemstra
Source:
International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Session:
The multiple facets of stem and progenitor cells in lung health and disease
Session type:
Oral Presentation
Number:
3518
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Winifred Broekman (Leiden, Netherlands), Winifred Broekman, Jan Stolk, Thais Mauad, Jaap Jan Zwaginga, Wim E. Fibbe, Jaap Oostendorp, Ingeborg Bajema, Michel I.M. Versteegh, Christian Taube, Pieter S. Hiemstra. Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial. Eur Respir J 2015; 46: Suppl. 59, 3518
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Preclinical studies of mesenchymal stem cell (MSC) transplantation in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Different response of lung tissue to intravenous acetylated opium
Source: International Congress 2015 – Different data in COPD
Year: 2015
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Oral presentation: Human lung parenchyma cells: a potential therapeutic cell source for lung disease
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair
Source: Eur Respir J 2004; 24 : 664-673
Year: 2004
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept